BACKGROUND
Artificial intelligence (AI) has the potential to improve cancer care. Its implementation must align with patients' needs, values, and lived experiences. This study aimed to explore perspectives from patient advocates representing patient organizations, including individuals with experience of melanoma, blad...
I. Budin-Ljøsne, Alessandro Boni, L. Boussemart et al.· Journal of Cancer Policy· 1 citation
These findings provide a comprehensive characterization of CTCs and CTACs in PC using a multiplex biomarker panel associated with calcium signaling and immune checkpoint pathways, highlighting the pronounced heterogeneity and potential clinical relevance of these circulating cell populations.
Chrysoula Tagari, Karolina Mangani, Michael Gogolides et al.· Frontiers in Cell and Develo...· 0 citations
The routine implementation of comprehensive genomic profiling in metastatic HER2-negative breast cancer, especially in metastatic HER2-negative breast cancer, is supported to guide precision oncology strategies and enable enrollment in biomarker-driven clinical trials.
E. Papadopoulou, M. Stathoulopoulou, M. Matiatou et al.· Cancer Genomics & Proteomics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.